Navigation Links
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Date:8/29/2010

oncology and vaccines research units in Cambridge.  Genzyme would become the global center for excellence for Sanofi-Aventis in rare diseases and further increase Sanofi-Aventis'  presence in the greater Boston area.
  • Continuation of Genzyme's Legacy within Sanofi-Aventis: Genzyme's rare disease business would be managed as a stand-alone division under the Genzyme brand, with its own R&D, manufacturing and commercial infrastructure, similar to how Sanofi-Aventis has handled other recent transactions.  Genzyme's management and employees would play a key role within Sanofi-Aventis following the acquisition.

  • Fully Financed, All-Cash Premium Offer: The purchase price would be paid in cash, offering immediate, substantial and certain value for Genzyme's shareholders.  Our offer is fully financed and is not subject to a financing contingency.

  • As I indicated in my July 29 letter to you, in addition to these compelling reasons, we believe there are many others that demonstrate why Sanofi-Aventis is the right partner for Genzyme.  Sanofi-Aventis has significant expertise executing and integrating acquisitions, and a strong track record of creating value through those acquisitions by enhancing their performance through leveraging Sanofi-Aventis' capabilities.  Sanofi-Aventis has demonstrated that it is a good corporate partner by enabling its affiliates to maintain their distinctive culture and focus on their core strengths.  Sanofi-Aventis is strong financially with a market capitalization of approximately $75 billion, annual revenue of approximately $38 billion and annual EBITDA of approximately $16 billion.  From Sanofi-Aventis' perspective, the proposed transaction would provide a new sustainable growth platform.

    It is our preference to work together with you and the Genzyme Board to reach a mutually agreeable transaction.   As we have consistently stated, we place
    '/>"/>

    SOURCE Sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
    2. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
    3. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
    4. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
    5. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
    6. Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
    7. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
    8. Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector
    9. Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
    10. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    11. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
    (Date:7/2/2015)... DUBLIN , June 25, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/8mfjxh/2015_new ) has announced the addition of ... Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, ... 2015 New Frontiers in Clinical ... Competitive Landscape is a new seven-country strategic ...
    (Date:7/2/2015)... , 2. Juli 2015 BGI gab ... in Hongkong vom American College of Pathologists ... ist das erste klinische Next-Generation-Sequencing Labor, das ... CAP-Zertifkat erhält und somit die höchsten Standards ... bestehenden US FDA - 21 CFR Part ...
    Breaking Medicine Technology:Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
    ... has activity in heavily pre-treated patients who have failed ... , PHILADELPHIA, Dec. 8 GlaxoSmithKline ... results from a pivotal trial pre-planned interim analysis of ... leukemia (CLL). The results demonstrate the potential of ofatumumab ...
    ... AMSTERDAM, December 8 ,Agendia, a world leader in ... the Netherlands Cancer Institute researchers will present,data from ... Cancer Symposium,(SABCS) and Agendia will support, with an ... Therapy symposium. The San Antonio,Breast Cancer Symposium, one ...
    Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 2Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 3Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 4
    (Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
    (Date:7/3/2015)... , ... July 03, 2015 , ... The Celebrity Dresses ... cocktail dresses similar to those of celebrities will have the opportunity to get 10% ... checkout. This ensures that people do not have to use coupon codes or remember ...
    (Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Texas. The opening is now the 19th sweetFrog store located in the Lone Star ... list of fastest growing companies in 2014. , The store, which opened July 1 ...
    (Date:7/2/2015)... , ... July 02, 2015 , ... ... parking structure retrofit project at the University of Minnesota, they knew it would ... it would also be an award-winning choice: the total energy savings after installation ...
    (Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was ... down to write his first poem, and three years later he was publishing an entire ... worth sharing with the world. "I have always believed that the best way to lift ...
    Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
    ... Medical School and the Harvard School of Public Health ... currently surrounding national health care reform. In a ... American Journal of Preventive Medicine, the Harvard research ... student in the Department of Population Medicine at HMS ...
    ... FRIDAY, July 15 (HealthDay News) -- Binge drinking can ... their environment or their surroundings) at a critical time ... new study. And, girls may be especially ... the researchers said. "Even though adolescents might ...
    ... News) -- Younger children respond better to treatment for lazy ... previous studies. The meta-analysis of data from 996 children ... Pediatric Eye Disease Investigator Group found that children ages 3 ... moderate and severe amblyopia than those aged 7 to less ...
    ... for Medical Systems Biology (BIMSB) of the Max Delbrck ... be the first academic research institution in Continental Europe ... of single DNA molecules in real time. The SMRT ... high-throughput technologies. The researchers of the BIMSB will use ...
    ... (HealthDay News) -- In an attempt to get smokers to ... taxes on cigarettes, yet many people remain undeterred by the ... the public health measure has prompted at least some low-income ... the International Journal of Environmental Research and Public Health ...
    ... a study, Identification of unrecognized diabetes and pre-diabetes in ... of the Journal of Dental Research, researchers ... dental visits represented a chance to intervene in the ... who are unaware of their condition. The study sought ...
    Cached Medicine News:Health News:Massachusetts health-care reform increased access to care, particularly among disadvantaged 2Health News:Binge Drinking May Impair Teen Brain Development 2Health News:Younger Kids Respond Better to 'Lazy Eye' Treatment 2Health News:Novel DNA sequencer for MDC's systems biology 2Health News:Cigarette Tax Unlikely to Deter Some Smokers: Report 2Health News:Dentists can identify people with undiagnosed diabetes, Columbia researchers show 2
    ... feature our internationally-acclaimed algorithm that is ... has a proven record for reliability ... and it's just one of several ... market leader in the stress testing ...
    ... Cardiac Stress Monitor combines Quinton ... muscle artifact filters, and 8000 ... the highest ECG fidelity in ... displayed in 3, 6, or ...
    ... system from Del Mar Reynolds Medical. Available ... bicycle ergometer, PC, Cart, isolation transformer and ... same CardioDirect patient interface module that is ... system is also available using the CardioCollect ...
    ... A breakthrough in non-invasive cardiac diagnosis, ... is the first and only stress test ... microvolt level. The pre-test lead check provides ... the WAVESTAR ECG filter that dynamically filters ...
    Medicine Products: